Abstract
In individuals who carry gcrmline mutations in tumor suppressor genes predisposing them to inherited cancer syndromes, occurrence of somatic mutations in the same genes contributes to tumorigenesis. Germline mutations in the RET proto‐oncogene predispose individuals to multiple endocrine neoplasia (MEN) type 2 syndromes. Since these mutations are oncogenic by themselves, somatic mutations in the same gene had been thought unnecessary. Recently, a somatic mutation at codon 918 of RET was reported in medullary thyroid carcinoma (MTC) and C‐cell hyperplasia in patients with MEN 2A or familial MTC (FMTC), suggesting its possible contribution to tumorigenesis. We describe here a novel somatic mutation at codon 919 in a patient with FMTC carrying a gcrmline mutation at codon 768 that may also be related to tumor progression.
Keywords: Familial medullary carcinoma, Germline mutation, Somatic mutation, RET proto‐oncogene
Full Text
The Full Text of this article is available as a PDF (253.1 KB).
REFERENCES
- 1. ) Knudson , A. G.Antioncogenes and human cancer . Proc. Natl. Acad. Sci. USA , 90 , 10914 – 10921 ( 1993. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. ) Santoro , M. , Carlomagno , F. , Romano , A. , Bottaro , D , P. , Dathan , N. A. , Grieco , M. , Fusco , A. , Vecchio , G. , Matoskova , B. , Kraus , M. H. and Fiole , P. P. D.Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B . Science , 267381 – 383 ( 1995. ). [DOI] [PubMed] [Google Scholar]
- 3. ) Mulligan , L. M. , Kwok , J. B. , Healey , C. S. , Elsdon , M. J. , Eng , C. , Gardner , E. , Love , D. R. , Mole , S. E. , Moore , J. K. , Papi , L. and Fiole , P. P. D.Germ‐line mutations of the RET proto‐oncogene in multiple endocrine neoplasia type 2A . Nature , 363458 – 460 ( 1993. ). [DOI] [PubMed] [Google Scholar]
- 4. ) Mulligan , L. M. , Eng , C. , Healey , C. S. , Clayton , D. , Kwok , J. B. , Gardner , E. , Ponder , M. A. , Frilling , A. , Jackson , C. E. , Lehnert , H. , Neumann , H. P. H. , Thibodeau , S. N. and Ponder , B. A. J.Specific mutations of the RET proto‐oncogene are related to disease phenotype in MEN 2A and FMTC . Nat. Genet. , 670 – 74 ( 1994. ). [DOI] [PubMed] [Google Scholar]
- 5. ) Hofstra , R. M. , Landsvater , R. M. , Ceccherini , L , Stulp , R. P. , Stelwagen , T. , Luo , Y. , Pasini , B. , Hoppener , J. W. , van Amstel , H. K. , Romeo , G. , Lips , C. J. M. and Buys , C. H. C.A mutation in the RET proto‐oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma . Nature , 367375 – 376 ( 1994. ). [DOI] [PubMed] [Google Scholar]
- 6. ) Asai , N. , Iwashita , T. , Matsuyama , M. and Takahashi , M.Mechanism of activation of the ret proto‐oncogene by multiple endocrine neoplasia 2A mutations . Mol. Cell. Biol. , 151613 – 1619 ( 1995. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. ) Marsh , D. J. , Andrew , S. D. , Eng , C. , Learoyd , D. L. , Capes , A. G. , Pojer , R. , Richardson , A. L. , Houghton , C. , Mulligan , L. M. , Ponder , B. A. J. and Robinson , B. G.Germline and somatic mutations in an oncogene: RET mutations in inherited medullary thyroid carcinoma . Cancer Res. , 561241 – 1243 ( 1996. ). [PubMed] [Google Scholar]
- 8. ) Wells , S. A. , Jr. , Baylin , S. B. , Linehan , W. M. , Farrell , R. E. , Cox , E. B. and Cooper , C. W.Provocative agents and the diagnosis of medullary carcinoma of the thyroid gland . Ann. Surg. , 188139 – 141 ( 1978. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. ) Ceccherini , I. , Hofstra , R. M. , Luo , Y. , Stulp , R. P. , Barone , V. , Stelwagen , T. , Bocciardi , R. , Nijveen , H. , Bolino , A. , Seri , M. , Ronchetto , P. , Pasini , B. , Bozzano , M. , Buys , C. H. C. M. and Romeo , G.DNA polymorphisms and conditions for SSCP analysis of the 20 exons of the ret proto‐oncogene . Oncogene , 93025 – 3029 ( 1994. ). [PubMed] [Google Scholar]
- 10. ) Eng , C. , Smith , D. P. , Mulligan , L. M. , Healey , C. S. , Zvelebil , M. J. , Stonehouse , T. J. , Ponder , M. A. , Jackson , C. E. , Waterfield , M. D. and Ponder , B. A.A novel point mutation in the tyrosine kinase domain of the RET protooncogene in sporadic medullary thyroid carcinoma and in a family with FMTC . Oncogene , 10509 – 513 ( 1995. ). [PubMed] [Google Scholar]
- 11. ) Mulligan , L. M. , Marsh , D. J. , Robinson , B. G. , Schuffenecker , L , Zedenius , J. , Lips , C. J. , Gagel , R. F. , Takai , S. I. , Noll , W. W. , Fink , M. , Raue , F. , Lacroix , A. , Thibodeau , S. N. , Frilling , A. , Ponder , B. A. J. , Eng , C.for the International RET Mutation Consortium: Genotype‐phenotype correlation in multiple endocrine neoplasia type 2: report of the International RET Mutation Consortium . J. Intern. Med. , 238 , 343 – 346 ( 1995. ). [DOI] [PubMed] [Google Scholar]
- 12. ) Orita , M. , Suzuki , Y. , Sekiya , T. and Hayashi , K.Rapid and sensitive detection of point mutations and DNA polymorphism using the polymerase chain reaction . Genomics , 5874 – 879 ( 1989. ). [DOI] [PubMed] [Google Scholar]
- 13. ) Bolino , A. , Schuffenecker , I. , Luo , Y. , Seri , M. , Silengo , M. , Tocco , T. , Chabrier , G. , Houdent , C. , Murat , A. , Schlumberger , M. , Tourinaire , J. , Lenoir , G. M. and Romeo , G.RET mutations in exons 13 and 14 of FMTC patients . Oncogene , 102415 – 2419 ( 1995. ). [PubMed] [Google Scholar]
- 14. ) Carlson , K. M. , Dou , S. , Chi , D. , Scavarda , N. , Toshima , K. , Jackson , C. E. , Wells , S. A. , Jr. , Goodfellow , P. J. and Donis‐Keller , H , Single missense mutation in the tyrosine kinase catalytic domain of the 'RET protooncogene is associated with multiple endocrine neoplasia type 2B . Proc. Natl. Acad. Sci. USA , 911579 – 1583 ( 1994. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. ) Farndon , J. R. , Leight , G. S. , Dilley , W. G. , Baylin , S. B. , Smallridge , R. C. , Harrison , T. S. and Wells , S. A. , Jr.Familial medullary thyroid carcinoma without associated endocrinopathies. A distinct entity . Br. J. Surg. , 73278 – 281 ( 1986. ). [DOI] [PMC free article] [PubMed] [Google Scholar]